HIGHLIGHTS
- who: Olivier Leroy from the (UNIVERSITY) have published the paper: Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study, in the Journal: (JOURNAL)
- what: The study primarily aimed to describe the prescribing practices for SAT in ICUs. The level of compliance of the participating ICUs with the ESCMID guidelines (at draft stage when the study was conducted) and with the IDSA guidelines was analyzed.
- how: Regarding ESCMID guidelines the compliance with the following recommendations was evaluated a preferred use of echinocandin the removal of any CVC in case of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.